The thing I'm most interested in is from the 2013 Annual Report:
"It is anticipated that Biotron will continue to signi?cantly advance its activities and, by 30 June 2014, we expect to have:
> prepared and submitted an Investigational New Drug (‘IND’) application for BIT225 to the US Food & Drug Administration (FDA)."
Fda approval will give BIT more flexibility in trials, and we should hope to see positive results from phase 3 trials :D
I think it might be time to be accumulating, when i get the $ together
The thing I'm most interested in is from the 2013 Annual...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.85M | |||
| Open | High | Low | Value | Volume |
| 2.2¢ | 2.2¢ | 2.2¢ | $45.42K | 2.064M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1098245 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 686481 | 2 |
View Market Depth
| Last trade - 14.35pm 18/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |